Trevi Therapeutics, Inc. (TRVI)
NASDAQ·Healthcare·Biotechnology
$13.34
-0.11%
Mkt Cap $1.80B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (14 analysts)
$29.67
Range $23.00 – $40.00
Implied Upside
+122.5%
Consensus $29.67 vs current $13.34
NASDAQ·Healthcare·Biotechnology
$13.34
-0.11%
Mkt Cap $1.80B
Buy
9
Hold
0
Sell
0
Price Target (14 analysts)
$29.67
Range $23.00 – $40.00
+122.5%
Consensus $29.67 vs current $13.34